MENU
Go to the list of all blogs
Allana's Avatar
published in Blogs
May 17, 2019

Five states to join lawsuit of OxyContin maker Purdue Pharma

Five U.S. states filed lawsuits accusing Purdue Pharma of illegally marketing and selling opioids, escalating the wave of litigation over a nationwide abuse epidemic. Iowa, Kansas, Maryland, West Virginia and Wisconsin joined 39 states to file lawsuits targeting Purdue Pharma and its leaders, including former president Richard Sackler and his family. 

Officials accused Purdue Pharma of repeatedly making false and deceptive claims that opioids, including OxyContin, were safe for a wide range of patients seeking to reduce pain. 

Purdue Pharma called the new lawsuits “misleading attacks.” “These complaints are part of a continuing effort to try these cases in the court of public opinion rather than the justice system,” the Stamford, Connecticut-based company said.

Related Ticker: FTXH

Momentum Indicator for FTXH turns positive, indicating new upward trend

FTXH saw its Momentum Indicator move above the 0 level on October 21, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for FTXH just turned positive on October 31, 2025. Looking at past instances where FTXH's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FTXH advanced for three days, in of 297 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 230 cases where FTXH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for FTXH moved out of overbought territory on November 20, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 22 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FTXH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

FTXH broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN), ZOETIS (NYSE:ZTS).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals TM Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.

Market Cap

The average market capitalization across the First Trust Nasdaq Pharmaceuticals ETF ETF is 54.78B. The market cap for tickers in the group ranges from 1.69B to 933.76B. LLY holds the highest valuation in this group at 933.76B. The lowest valued company is PRGO at 1.69B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust Nasdaq Pharmaceuticals ETF ETF was -0%. For the same ETF, the average monthly price growth was 7%, and the average quarterly price growth was 26%. EXAS experienced the highest price growth at 49%, while PRGO experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the First Trust Nasdaq Pharmaceuticals ETF ETF was -9%. For the same stocks of the ETF, the average monthly volume growth was 58% and the average quarterly volume growth was 76%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 65
Price Growth Rating: 44
SMR Rating: 66
Profit Risk Rating: 62
Seasonality Score: 24 (-100 ... +100)
View a ticker or compare two or three
FTXH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Wheaton
Phone
N/A
Web
www.ftportfolios.com
Interact to see
Advertisement
On May 16, 2025, Moody's Ratings downgraded the United States' sovereign credit rating from its pristine AAA to Aa1, citing concerns over the nation's ballooning $36 trillion debt.
#trading
Tickeron, Inc., a leading provider of AI-driven trading tools, is thrilled to announce the launch of its token on the innovative Believe App, a platform revolutionizing community-driven funding.
#trading
Discover how AI-powered Dual Agent Trading Bots are transforming emotional trading into data-driven strategy. From mastering fear and greed to using inverse ETFs and pattern recognition, this article reveals how Tickeron's Agentic AI enables smarter, adaptive market moves.
#trading
Walmart’s stock is up nearly 54% in 2025, fueled by strong earnings, e-commerce growth, and investor confidence. This article explores Walmart’s financials, AI-driven analysis tools from Tickeron, and how traders are navigating market volatility with WMT.
#trading
Alphabet Inc. (GOOG, GOOGL), the parent company of Google, today released a financial update highlighting its performance and strategic initiatives as it approaches its Q2 2025 earnings report on July 29.
A routine Treasury bond auction shook markets on May 21, 2025, triggering an 80-point S&P 500 plunge as yields spiked above 5%. Explore what caused the sudden drop, how macroeconomic pressures played a role, and how Tickeron’s AI trading bots capitalized on the chaos.
#investment#trading
Ethereum ($ETH) is nearing a potential breakout above $4,000 as its 3-day chart forms a bullish Descending Broadening Wedge. With AI trading tools like Tickeron’s proven agents, traders are watching closely for a move that could define the next major crypto trend.
Bitcoin has officially hit $109,000 on May 21, 2025—exactly as predicted by Tickeron’s AI nearly two months ago. This milestone validates the platform’s AI accuracy and highlights how traders can use Tickeron’s AI Double Agents to navigate crypto market volatility with confidence.
Ethereum (ETH) is capturing the attention of traders and analysts alike, with its 3-day chart forming a Descending Broadening Wedge pattern—a classic technical setup that often precedes significant price movements.
#artificial_intelligence#trading
Tickeron, a leading provider of AI-driven trading tools, shared a bold prediction on X.com about Bitcoin’s (BTC) price trajectory.
#artificial_intelligence#trading
A turbulent week rocked global markets as the S&P 500 slid 3% following a U.S. credit downgrade, while Bitcoin surged past $111K and gold soared. Strong UK inflation and retail sales data added to the volatility, highlighting growing concerns over global economic stability.
Learn how to identify the four key market phases—Accumulation, Uptrend, Distribution, and Downtrend—and strategically trade each using Tickeron’s AI-powered Double Agent system. Discover how adaptive automation helps maximize gains and minimize risk across all market conditions.
#investment#artificial_intelligence
Learn how to identify the four key market phases—Accumulation, Uptrend, Distribution, and Downtrend—and strategically trade each using Tickeron’s AI-powered Double Agent system. Discover how adaptive automation helps maximize gains and minimize risk across all market conditions.
#artificial_intelligence#trading
Tickeron, a leader in AI-powered financial solutions, proudly announces the launch of its Double Agent Trading Bot, designed for trading Carpenter Technology Corporation (CRS) and Direxion Daily Semiconductor Bear 3x Shares (SOXS).
#artificial_intelligence
Apple Inc. (AAPL), a global leader in consumer electronics, continues to be a cornerstone of the technology sector, driving innovation and commanding significant market attention.
#artificial_intelligence
NVIDIA’s earnings on May 28 could jolt the tech sector. With market volatility rising, traders are turning to Tickeron’s AI Agent for real-time insights, predictive analytics, and dual-strategy trading tools to navigate potential price swings and seize market opportunities.
#artificial_intelligence
As the DOJ and FTC move to break up Google’s search dominance and impose AI investment oversight, the tech giant faces a pivotal legal battle that could reshape the digital and AI landscapes—creating major implications for investors, competitors, and consumers alike.
#artificial_intelligence
GameStop (GME) continues to captivate investors with its explosive volatility and strong retail sentiment. As AI tools highlight bullish signals and a possible breakout, traders weigh the risks of speculation against the potential rewards in May 2025.
#artificial_intelligence
Mastercard (MA) continues to impress investors with strong earnings, rising digital payments, and bullish AI-driven signals. Backed by robust financials and cutting-edge trading tools from Tickeron, MA stands out as a leader in the fintech space for 2025.